Safety, Tolerability, and Efficacy of Axatilimab, a Colony-Stimulating Factor 1 Receptor (CSF-1R) Humanized Antibody, in Advanced Chronic Graft-versus-host Disease-Related Bronchiolitis Obliterans Syndrome

Abstract | May 1, 2023

Author

Radojcic V, et al.

Congress

American Thoracic Society 2023

Washington, DC | Oct 4 – 8, 2023